Last reviewed · How we verify
NCT02982096
Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique
NA trial testing Cellutome Device in Burn Wound in 9 participants. Completed in 1 December 2022.
1 December 2022
Quick facts
| Lead sponsor | Lehigh Valley Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 9 |
| Start date | 23 August 2016 |
| Primary completion | 1 December 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cellutome Device
- Standard of Care
Conditions studied
- Burn Wound — all drugs for Burn Wound →
Sponsor
Lehigh Valley Hospital
Who can join
18 and older, any sex, with Burn Wound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if healing occurs within 21 days of treatment with the use of the CellutomeTM device for fractional epidermal micro grafting compared with standard acellular techniques (creams and membrane dressings). Healing will be determined by time to ≥90% epithelialization within 21 days of treatment. Cosmesis (as assessed by Vancouver Scar Scale (VSS), Patient Observer Scar Assessment Scale (POSAS), erythema, pigmentation, elasticity, thickness, and sensation) will be compared to standard techniques without application of skin cells (epidermal grafts = acellular) and will be measured twelve months post treatment application, ± 6 months.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Advancements in Regenerative Strategies Through the Continuum of Burn Care.
Stone Ii R, Natesan S, Kowalczewski CJ, Mangum LH, et al · · 2018 · cited 73× · PMID 30038569 · DOI 10.3389/fphar.2018.00672
Verify or expand the search:
- PubMed search for NCT02982096
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burn Wound
Currently open trials in the same condition.
- NCT06807021 — Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients · Phase 2, PHASE3 · recruiting
- NCT06913270 — Virtual Reality Adjunct for Procedural Pain and Anxiety Management in Burn Wound Care · NA · recruiting
Other Lehigh Valley Hospital trials
Trials by the same sponsor.
- NCT05506631 — Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02982096 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lehigh Valley Hospital
- Last refreshed: 10 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02982096.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing